These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8653191)

  • 21. A cost analysis of treating pediatric dental patients using general anesthesia versus conscious sedation.
    Lee JY; Vann WF; Roberts MW
    Pediatr Dent; 2000; 22(1):27-32. PubMed ID: 10730283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to high cost drugs in Australia.
    Lu CY; Williams K; Day R; March L; Sansom L; Bertouch J
    BMJ; 2004 Aug; 329(7463):415-6. PubMed ID: 15321884
    [No Abstract]   [Full Text] [Related]  

  • 23. Research note: does cost recovery for curative care affect preventive care utilization?
    Yazbeck A; Leighton C
    Health Policy Plan; 1995 Sep; 10(3):296-300. PubMed ID: 10151846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accounting for the health-care bill.
    Batavia AI
    Lancet; 2003 Nov; 362(9394):1495-7. PubMed ID: 14602447
    [No Abstract]   [Full Text] [Related]  

  • 25. Bundled payment for actinic keratosis management: Pilot evaluation of developed models.
    Kirby JS; Silva CF; Ferguson SB; Shupp D; Marks JG; Miller JJ
    J Am Acad Dermatol; 2019 Mar; 80(3):679-684. PubMed ID: 30744876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simulation model to evaluate pharmaceutical supply chain costs in hospitals: the case of a Colombian hospital.
    Franco C
    Daru; 2020 Jun; 28(1):1-12. PubMed ID: 30565158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copayments for medicines. How much should patients pay?
    Burstall ML
    Pharmacoeconomics; 1994 Sep; 6(3):187-92. PubMed ID: 10155261
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of financing and quality changes on health care demand in Niger.
    Chawla M; Ellis RP
    Health Policy Plan; 2000 Mar; 15(1):76-84. PubMed ID: 10731238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost recovery for drugs provided at the rural dispensary: an experiment in Niger.
    Juncker T
    Ann Soc Belg Med Trop; 1993 Sep; 73(3):235-46. PubMed ID: 8279871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative cost of medical care. OSMA presents medical cost figures in perspective before legislative study committee on consumer affairs.
    Price CF
    Ohio State Med J; 1970 Oct; 66(10):1047-8. PubMed ID: 4990238
    [No Abstract]   [Full Text] [Related]  

  • 31. Episodic acute care costs: linking inpatient and home care.
    Jacobs P; Hall E; Henderson I; Nichols D
    Can J Public Health; 1995; 86(3):200-5. PubMed ID: 7671208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The true cost of pharmacological disease prevention.
    Järvinen TL; Sievänen H; Kannus P; Jokihaara J; Khan KM
    BMJ; 2011 Apr; 342():d2175. PubMed ID: 21505222
    [No Abstract]   [Full Text] [Related]  

  • 33. Patent medicine dealers and irrational use of medicines in children: the economic cost and implications for reducing childhood mortality in southeast Nigeria.
    Uzochukwu BS; Onwujekwe OE; Okwuosa C; Ibe OP
    PLoS One; 2014; 9(3):e91667. PubMed ID: 24621618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The cost-benefit ratio of health care].
    Vuori H
    Sairaanh Vuosik; 1971; 8():156-68. PubMed ID: 4997248
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost of preventive drugs. Dare to tell?
    Trewby PN
    BMJ; 2011 May; 342():d3198. PubMed ID: 21610062
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: Drugs; supply, quality & cost.
    Ceylon Med J; 1975 Jun; 20(2):67-8. PubMed ID: 1157195
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost recovery in Mauritania: initial lessons.
    Audibert M; Mathonnat J
    Health Policy Plan; 2000 Mar; 15(1):66-75. PubMed ID: 10731237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis on the drug utilization in years 1961, 1963 and 1965 with special consideration of increase rate in out-patient section of the district Gadebusch, region Schwerin].
    Bretschneider K
    Pharm Prax; 1968; 12():305-18. PubMed ID: 5753478
    [No Abstract]   [Full Text] [Related]  

  • 39. The great medicines scandal: access is not just about cost.
    Waning BJ
    BMJ; 2006 Jul; 333(7557):44. PubMed ID: 16809717
    [No Abstract]   [Full Text] [Related]  

  • 40. [Certain economical aspects of drug supply to the intensive care departments].
    Ermakov VV; Troshina IM; Markova AI; Syrkin AL; Alekseeva VM
    Sov Med; 1975 Mar; (3):131-4. PubMed ID: 1154089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.